IR Main
Consolidated
Consolidated Statements of Income
| field | year | 2025 | ||||||
|---|---|---|---|---|---|---|---|---|
| 4Q24 | 4Q25 | YoY | YoY(%) | 1Q | 2Q | 3Q | 4Q | |
|
Revenues
|
7,864,033
|
8,099,148
|
235,114
|
3.0
|
1,860,594
|
2,024,196
|
2,081,159
|
2,133,199
|
|
Operating Expenses
|
7,368,756
|
7,367,111
|
-1,644
|
-0.0
|
1,745,654
|
1,828,897
|
1,862,806
|
1,929,755
|
|
Operating Profit
|
495,278
|
732,037
|
236,759
|
47.8
|
114,940
|
195,299
|
218,353
|
203,445
|
|
Other Non-Operating Income
|
172,644
|
314,075
|
141,431
|
81.9
|
103,579
|
75,541
|
43,176
|
91,779
|
|
Other Non-Operating Expenses
|
711,984
|
508,827
|
-203,157
|
-28.5
|
28,074
|
72,468
|
42,070
|
366,215
|
|
Financial Income
|
405,185
|
392,559
|
-12,626
|
-3.1
|
100,629
|
53,573
|
70,088
|
168,270
|
|
Financial Expenses
|
367,898
|
397,935
|
30,037
|
8.2
|
123,086
|
71,051
|
44,197
|
159,601
|
|
Equtiy method Profit
|
147,351
|
153,513
|
6,162
|
4.2
|
50,751
|
35,175
|
34,772
|
32,816
|
|
Equtiy method Loss
|
90,910
|
63,885
|
-27,025
|
-29.7
|
16,415
|
11,661
|
15,134
|
20,676
|
|
Profit before Income Tax
|
49,665
|
621,536
|
571,871
|
1151.4
|
202,324
|
204,406
|
264,988
|
-50,182
|
|
Income Tax
|
160,486
|
94,701
|
-65,784
|
-41.0
|
-7,426
|
23,201
|
61,686
|
17,239
|
|
Net Profit
|
-161,871
|
517,960
|
679,830
|
420.0
|
200,334
|
171,815
|
192,863
|
-47,052
|
Unit: KRW million, %
※ Following the completion of the disposal process of the healthcare business division (consisting of Kakao Healthcare and its subsidiaries) in 4Q25, the relevant gains and losses have been classified as discontinued operations; accordingly, the financial results for the current, preceding, and the same period of the previous year have been restated on a continuing operations basis to ensure comparability.
Consolidated Statements of Financial Position
| field | year | 2025 | ||||||
|---|---|---|---|---|---|---|---|---|
| 4Q24 | 4Q25 | YoY | YoY(%) | 1Q | 2Q | 3Q | 4Q | |
|
Current Assets
|
10,721,670
|
12,374,176
|
1,652,506
|
15.4
|
10,639,790
|
11,267,556
|
12,141,154
|
12,374,176
|
|
Non-Current Assets
|
15,051,358
|
15,409,349
|
357,991
|
2.4
|
15,262,481
|
15,295,020
|
14,750,204
|
15,409,349
|
|
Total Assets
|
25,773,028
|
27,783,525
|
2,010,496
|
7.8
|
25,902,271
|
26,562,575
|
26,891,358
|
27,783,525
|
|
Current Liabilities
|
8,545,228
|
8,779,746
|
234,518
|
2.7
|
8,291,221
|
8,189,437
|
8,620,025
|
8,779,746
|
|
Non-Current Liabilities
|
3,284,906
|
3,778,856
|
493,950
|
15.0
|
3,275,728
|
3,783,588
|
3,617,981
|
3,778,856
|
|
Total Liabilities
|
11,830,134
|
12,558,603
|
728,468
|
6.2
|
11,566,948
|
11,973,025
|
12,238,006
|
12,558,603
|
|
Paid-in Capital
|
44,416
|
44,300
|
-117
|
-0.3
|
44,437
|
44,251
|
44,282
|
44,300
|
|
Capital Surplus
|
8,911,043
|
8,803,321
|
-107,722
|
-1.2
|
8,913,976
|
8,825,215
|
8,820,839
|
8,803,321
|
|
Othter Accumulated Earnings
|
-34,079
|
-82,389
|
-48,310
|
-141.8
|
-32,551
|
-88,731
|
-86,642
|
-82,389
|
|
Accumulated Other Comprehensive Income
|
-723,579
|
-173,534
|
550,044
|
76.0
|
-619,288
|
-467,357
|
-812,022
|
-173,534
|
|
Retained Earnings
|
1,943,498
|
2,684,520
|
741,022
|
38.1
|
2,086,014
|
2,261,557
|
2,648,785
|
2,684,520
|
|
Minority Interest
|
3,801,594
|
3,948,704
|
147,110
|
3.9
|
3,942,735
|
4,014,616
|
4,038,110
|
3,948,704
|
|
Total Equity
|
13,942,894
|
15,224,922
|
1,282,028
|
9.2
|
14,335,322
|
14,589,550
|
14,653,352
|
15,224,922
|
|
Total Liabilities and Equity
|
25,773,028
|
27,783,525
|
2,010,496
|
7.8
|
25,902,271
|
26,562,575
|
26,891,358
|
27,783,525
|
Unit: KRW million, %
※ Following the completion of the disposal process of the healthcare business division (consisting of Kakao Healthcare and its subsidiaries) in 4Q25, the relevant gains and losses have been classified as discontinued operations; accordingly, the financial results for the current, preceding, and the same period of the previous year have been restated on a continuing operations basis to ensure comparability.
Consolidated Statements of Cash Flows
| field | year | 2025 | ||||||
|---|---|---|---|---|---|---|---|---|
| 4Q24 | 4Q25 | YoY | YoY(%) | 1Q | 2Q | 3Q | 4Q | |
|
Operating activities
|
1,250,459
|
1,404,763
|
154,304
|
12.3
|
222,217
|
623,769
|
937,023
|
1,404,763
|
|
Investing activities
|
10,423
|
-478,201
|
-488,624
|
-4688.1
|
-472,725
|
-543,797
|
-136,000
|
-478,201
|
|
Financing activities
|
-521,317
|
708,212
|
1,229,529
|
235.9
|
-364,383
|
-493,765
|
-592,331
|
708,212
|
|
Effect of exchange rate fluctuations on cash held
|
47,894
|
-21,214
|
-69,108
|
-144.3
|
19,795
|
-14,308
|
-6,990
|
-21,214
|
|
Net increase (decrease) in cash
|
787,458
|
197,136
|
-590,323
|
-75.0
|
-595,096
|
-428,101
|
201,701
|
197,136
|
|
Net increase (decrease) in cash
|
-6,883
|
6,883
|
-
|
200.0
|
6,883
|
6,883
|
6,883
|
6,883
|
|
Cash at beginning of period
|
5,389,191
|
6,169,766
|
780,575
|
14.5
|
6,169,766
|
6,169,766
|
6,169,766
|
6,169,766
|
|
Cash at end of period
|
6,169,766
|
6,373,784
|
204,019
|
3.3
|
5,581,553
|
5,748,548
|
6,378,350
|
6,373,784
|
Unit: KRW million, %